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Special Studies

Cytochemical Studies
Smears were prepared from marrow aspirated at presentation (>90% leukemic blasts). Wright-Giemsa, methyl green pyronin (MGP), and oil red 0 stains were done as described.
16 Wright-Giemsa stained blasts (Fig.  1 ) demonstrated the characteristic cytoplasmic vacuoles and intense basophilia of Burkitt leukemia cells. The cytoplasm was MGP positive, and the cytoplasmic vacuoles were oil red 0 positive. Peroxidase, periodic acidSchiff (PAS), alpha napthyl-acetate esterase with and without fluoride inhibition, acid phosphatase, and beta glucuronidase stains (kindly performed by Dr. John Bennett, University of Rochester, School of Medicine) all had negative results.
Ultrastructural Studies
Marrow particles were fixed in 3.8% paraformaldehyde in Millonig's buffer, overlaid in 2% agar, postfixed in 2% osmium tetroxide, and embedded in Epon 812. Sections were cut on an LKB ultratome 3, doubly stained with uranyl acetate and lead citrate, and viewed with a Phillips 300® transmission electron microscope. A representative leukemic blast (Fig. 2) demonstrates lipid laden vacuoles, prominent ribosomes, and absence of primary granules consistent with the lymphoblastic nature of the cells.
Immunologic Typing Studies
Blast cell suspensions were prepared by Ficoll-Hypaque® density gradient centrifugation, 14 then washed three times to remove unbound proteins. Surface immunoglobulins (slg) and cytoplasmic immunoglobulins (clg) were detected as described 1 by direct immunofluorescence employing monospecific (Fabi) fragments of fluorescein-conjugated anti-human heavy chain (IgG, IgA, IgM, IgD) and light chains (kappa, lambda) Meloy Labs, Springfield, Virginia). A minimum of 200 leukemic blasts were scored for reactivity employing a Zeiss® immunofluorescence microscope. Controls were always less than 5% positive. Slg was not detected employing monospecific FITC conjugated antibodies to either heavy or light chains. However, 53% and 51% of leukemic blasts demonstrated intracytoplasmic IgG (Fig. 3) and lambda, respectively. Intracytoplasmic IgM, IgA, IgD, or Kappa chains were not detected. An indirect immunofluorescent technic as described by the manufacturer was employed to detect the common acute lymphoblastic leukemic antigen (CALLA [J-5], Coulter Electronics, Hialeah, FL), a pan B-cell antigen (Bl, Coulter Electronics), an E-rosette receptor antigen (OKT11, Ortho Pharmaceuticals, Raritan, NJ), and a pan T-cell antigen (OKT3, Ortho Pharmaceuticals). antibodies, respectively. Only 5% and 9% of the blasts reacted with the T-cell antibodies OKT3 and OKT11, respectively. SIg studies and monoclonal antibody studies were repeated after second relapse and gave similar results. In summary, the leukemic blasts were CALLA+, B1+, SIg-, c IgG+, c IgM-, OKT3-, OKT11-.
Cytogenetics
Chromosome analyses were performed by direct technics and after 24 hours in culture on marrow specimens replaced with (>90%) blasts employing a trypsin-Giemsa binding technic. 25 No chromosomal abnormalities were detected in 20 metaphases from marrow cell suspension studied at presentation before treatment. After relapse, cytogenetic studies of bone marrow were repeated and 28 metaphases were examined (Fig. 4) . The chromosome numbers were 45 (5 cells), 46 (2), 47 (20) and 48 (1). The two cells with 46 chromosomes were the only normal cells present. The cell with 48 chromosomes possessed the karyotype 48 XY l q -7q-12p-with two marker chromosomes. M1 resembled the long arm of chromosome No. 1 but was larger and possessed a centromere (Fig. 4) . M2 could not be identified but also possessed a centromere. The remaining 25 cells all possessed Ml, and 13 of them also possessed M2. The cells with 45 chromosomes, and those with 47 chromosomes but possessing both Ml and M2, all showed apparently random losses of other chromosomes. Thus, there appeared to be two distinct but related cell lines: 47 XY l q -7q-12p-Ml and 48 XY l q -7q-12p-Ml M2. The cells with 47 chromosomes and both markers appeared to represent members of the 48-chromosome line that had sustained random chromosome loss and not another cell lineage. A careful search did not disclose any abnormalities of chromosomes 2, 8, 14, or 22.
Discussion
The leukemic blasts in L-3 ALL usually display surface immunoglobulin (SIg) and a translocation between chromosomes 8 and 14, (t 8;14) . 2, 3, 9, 13, 29 Because these features also are found in the morphologically identical Burkitt's lymphoma cells (BL), 17 it has been suggested that these malignancies are different manifestations of the same disease, involving a lymphocyte committed to the B-cell lineage.
3 However, exceptions to these findings have been noted. A variety of slglymphomas potentially may masquerade as L-3 ALL if blood and marrow invasion occurs. 17 In addition, three cases of an acute nonlymphocytic leukemia (ANLL), one with erythroleukemia 8 and two with acute myelomonocytic leukemia, have been reported with L-3 morphology. 5 There is even one case of metastatic carcinoma with this morphology. 5 Rarely a T-cell ALL or null cell ALL has been described with L-3 morphology. 5101419, 29 In only one of these cases was intracytoplasmic immunoglobulin examined and IgM found. 10 To our knowledge, the present case is the first report of an L-3 ALL lacking surface immunoglobulin and T-cell markers but with intracytoplasmic IgG. These cases underscore the need for extensive immunologic, histochemical, and ultrastructural studies in L-3 ALL before a definitive diagnosis can be made.
Despite the absence of SIg on our patient's blasts, the B-cell lineage of the leukemia clearly was documented by the expression of the Bl antigen and intracytoplasmic IgG. The Bl antigen is expressed in all B-cell differentiation stages except the plasma cell. 23 The absence of SIg and the presence of intracytoplasmic IgG suggests that a leukemogenic event may have occurred in a pre-B-cell. Ganick and Finlay previously have reported one case of L-3 ALL lacking surface immunoglobulin but with intracytoplasmic IgM.
10 Although the presence of intracytoplasmic IgM and absent surface immunoglobulin usually defines a pre-B-cell, 6 Vogler has noted a small portion of leukemic blasts that contain detectable cytoplasmic IgG or IgA. 30 The present case may represent an expansion of this uncommon pre-B-cell phenotype.
In two recent reviews of cytogenetic findings in L-3 ALL, 3,29 almost all cases had abnormalities involving chromosomes 14, 2 or 22, the location of genes encoding heavy and light chain immunoglobulin synthesis. 1218, 20 The most common abnormalities were t 8; 14 or variants: 14 q+, t 8;22, or t 2;8. 3, 29 Only five cases of L-3 ALL have been reported lacking involvement of chromosomes 8 or 14: one patient had t 4;11, 29 another 6q-, 26 and a third, an abnormality of chromosome 1. 27 In addition to our patient, only two other patients with L-3 ALL have been reported with normal chromosomes.
7,29 A single patient, reported by the International Workshop, 29 with cells lacking surface immunoglobulin and the t 8; 14, resembles our case; intracytoplasmic immunoglobulin studies were not done. It seems unlikely that nonleukemic cells were responsible for the normal karyotype observed in our case at presentation since studies were done directly and after 24 hours in culture from marrow packed with leukemic blasts. Furthermore, we did not see an evolution of a (t 8; 14) clone or related abnormality over a 33-month period. When the karyotype was studied late in the course of the disease, our patient had a 7q-aberration and a marker chromosome resembling the long arm of chromosome 1 but not identical with it. These abnormalities have been noted previously in patients with ALL and lymphoma. MANGAN 14, 2, or 22, our case illustrates that rearrangements in these chromosomes involved in immunoglobulin synthesis may not be required in all instances for evolution of a lymphoblastic leukemia with Burkitt morphology.
